Inogen (INGN) Gets a Buy from Needham

In a report released today, Michael Matson from Needham maintained a Buy rating on Inogen (INGNResearch Report), with a price target of $36.00. The company’s shares opened today at $21.96.

According to TipRanks, Matson is an analyst with an average return of -0.9% and a 44.12% success rate. Matson covers the Healthcare sector, focusing on stocks such as Atricure, Medtronic, and NeoGenomics.

Currently, the analyst consensus on Inogen is a Moderate Buy with an average price target of $36.00.

See the top stocks recommended by analysts >>

Based on Inogen’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $103.38 million and a GAAP net loss of $3.44 million. In comparison, last year the company earned a revenue of $101.56 million and had a net profit of $5.1 million

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home. The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More